Early Genomic Indicators of Praziquantel Resistance in Schistosoma mansoni

Summary

Article discusses early genomic indicators of praziquantel resistance in Schistosoma mansoni, a parasite affecting over 250 million people worldwide with 90% of infections in sub-Saharan Africa. This is a research/information article with no clinical trial data, regulatory decisions, or company-specific developments.